Search
Maravai LifeSciences Holdings Inc
MRVIAdd to Watchlist
7.520USD
+0.540+7.74%
Close 11-06 16:00（ET）
1.95BMarket Cap
LossP/E TTM
Maravai LifeSciences Holdings Inc (MRVI) Stock Price Target & Forecast
Analyst Rating
Based on 9 analysts giving stock ratings to Maravai LifeSciences Holdings Inc in the past month.
Buy
2 Strong Buy
3 Buy
4 Hold
0 Sell
0 Strong Sell
Target Price
8.500USD+8.83%
MRVI Analyst Recommendation Trends
In the current month, MRVI has received 3 Buy Ratings, 4 Hold Ratings, and 0 Sell Ratings. MRVI average Analyst price target in the last month is 8.500.
2026-11
2026-10
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2
2
2
2
2
2
2
2
3
3
3
3
3
3
3
3
4
4
4
4
5
5
6
6
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
9
9
9
9
10
10
11
11
MRVI Analyst Rating for Peer Comparison
Updated: Nov 5, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
Beigene Ltd
ONC
8
19
0
0
0
27
argenx SE
ARGX
10
14
3
0
0
27
Ionis Pharmaceuticals Inc
IONS
6
16
4
0
0
26
Insmed Inc
INSM
6
18
1
0
0
25
Revolution Medicines Inc
RVMD
10
14
1
0
0
25
CRISPR Therapeutics AG
CRSP
4
8
11
0
0
23
Tempus AI Inc
TEM
4
7
11
0
1
23
Kymera Therapeutics Inc
KYMR
9
12
2
0
0
23
Biontech SE
BNTX
4
12
6
0
0
22
IQVIA Holdings Inc
IQV
8
13
1
0
0
22
Financial Forecasting
Based on analysts' estimates, MRVI EPS is projected to reach -0.046 in FY2026Q4, following reported EPS of -0.093 in FY2026Q3. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
FY2027Q1
Forecast
-0.05
-0.04
-0.06
-0.05
-0.01
Actual
-0.03
-0.08
-0.09
--
--
Surprise
+45.92%
-93.97%
-63.83%
--
--
FAQs
What is Maravai LifeSciences Holdings Inc's expected revenue for the next quarter?
Maravai LifeSciences Holdings Inc's expected revenue is 51.18M.
What is Maravai LifeSciences Holdings Inc's price target?
Analysts forecast that Maravai LifeSciences Holdings Inc's price target is USD 8.75, with the highest forecast at USD 12.00 and the lowest forecast at USD 7.00.
How have Maravai LifeSciences Holdings IncMRVI's recent earnings per share performed?
The market expectation was USD -0.09, while Maravai LifeSciences Holdings IncMRVI's earnings per share (EPS) for the previous quarter was USD -0.08. EPS for the next quarter is expected at USD -0.05.
What is the analyst rating for Maravai LifeSciences Holdings Inc?
Based on the ratings of Maravai LifeSciences Holdings Inc's stock from 9 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.